Quick Overview: The GLP-1 drug revolution has taken the medicine world by storm. I've done several episodes on the science of GLP-1s. The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker What is the significance of intellectual property to life science companies? What do most of the public not understand about ...

Eli Lilly Ceo David Ricks - Detailed Overview & Context

The GLP-1 drug revolution has taken the medicine world by storm. I've done several episodes on the science of GLP-1s. The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker What is the significance of intellectual property to life science companies? What do most of the public not understand about ... On this episode of inSpired, Mike Rockefeller, Co-Chief Investment Officer of Woodline, manager of the Woodline Spire funds, ... The Economic Club of Washington, D.C. is pleased to announce that

Photo Gallery

Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
The Future of GLP-1 Drugs and AI Medicine, With Eli Lilly CEO David Ricks | Plain English
Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
NVIDIA & Lilly: The AI Revolution in Drug Discovery | Jensen Huang & David Ricks
David A. Ricks, Chair & CEO, Eli Lilly and Company
Eli Lilly CEO: Our pill supply can 'reach the planet'
Eli Lilly’s CEO David Ricks delves into the drivers of the healthcare industry
David Ricks - CEO of Eli Lilly | Podcast | In Good Company | Norges Bank Investment Management
Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results
Dave Ricks, CEO of Eli Lilly: How a 150 Year Old Company Keeps Winning
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored